NDC 15631-0210

GRAPHITES

Graphites

GRAPHITES is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Graphite.

Product ID15631-0210_a144c67d-bcd1-5162-e053-2995a90a7e3b
NDC15631-0210
Product TypeHuman Otc Drug
Proprietary NameGRAPHITES
Generic NameGraphites
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameGRAPHITE
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0210-0

100 PELLET in 1 PACKAGE (15631-0210-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0210-1 [15631021001]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0210-5 [15631021005]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0210-2 [15631021002]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0210-0 [15631021000]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0210-3 [15631021003]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0210-4 [15631021004]

GRAPHITES PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

Drug Details

Active Ingredients

IngredientStrength
GRAPHITE1 [hp_X]/1

OpenFDA Data

SPL SET ID:b1267050-2536-47bc-9ed7-89ce49f3d388
Manufacturer
UNII

NDC Crossover Matching brand name "GRAPHITES" or generic name "Graphites"

NDCBrand NameGeneric Name
0220-2325GraphitesGRAPHITE
0220-2360GraphitesGRAPHITE
0220-2361GraphitesGRAPHITE
0220-2362GraphitesGRAPHITE
0220-2363GraphitesGRAPHITE
0220-2364GraphitesGRAPHITE
0220-2365GraphitesGRAPHITE
0220-2366GraphitesGRAPHITE
0220-2367GraphitesGRAPHITE
0220-2368GraphitesGRAPHITE
0220-2369GraphitesGRAPHITE
0360-0188GRAPHITESGRAPHITES
0360-0189GRAPHITESGRAPHITES
10191-1795GRAPHITESGRAPHITE
10191-1797GRAPHITESGRAPHITE
15631-0210GRAPHITESGRAPHITES
15631-0594GRAPHITESGRAPHITES
15631-2315GRAPHITESGRAPHITES
37662-0785GraphitesGraphites
37662-0786GraphitesGraphites
37662-0787GraphitesGraphites
37662-0788GraphitesGraphites
37662-0789GraphitesGraphites
37662-0790GraphitesGraphites
37662-0791GraphitesGraphites
37662-0792GraphitesGraphites
60512-6075GRAPHITESGRAPHITES
62106-5058GRAPHITESPlumbago
68428-412GraphitesGRAPHITE
71919-324GraphitesGRAPHITE
10191-1794GRAPHITEGRAPHITES
69152-1080Graphites 200CGraphites

Trademark Results [GRAPHITES]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GRAPHITES
GRAPHITES
74578558 not registered Dead/Abandoned
MORSE SHOE, INC.
1994-09-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.